Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Testing effectiveness (Phase 2)Looking for participantsNCT06420076
What this trial is testing

Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells

Who this might be right for
T Cell LymphomaT Cell LeukemiaT-cell Acute Lymphoblastic Leukemia+3 more
Essen Biotech 60
Not applicableUnknownNCT04785833
What this trial is testing

CD7 CAR-T in the Treatment of CD7 Positive Refractory Relapsed Acute Leukemia

Who this might be right for
T-ALL
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 20
Early research (Phase 1)Study completedNCT05290155
What this trial is testing

Anti-CD7 CAR-T Cell Therapy for Relapse and Refractory CD7 Positive T Cell Malignancies

Who this might be right for
T Lymphoblastic Leukemia/LymphomaT-cell Acute Lymphoblastic LeukemiaPeripheral T Cell Lymphoma+2 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 14
Early research (Phase 1)Looking for participantsNCT06732492
What this trial is testing

RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies

Who this might be right for
NK T-Cell LymphomaCART TherapyCD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 10
Early research (Phase 1)UnknownNCT05170568
What this trial is testing

PA3-17 Injection Treatment of Adult Patients With CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies

Who this might be right for
CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 22
Testing effectiveness (Phase 2)UnknownNCT04762485
What this trial is testing

Humanized CD7 CAR T-cell Therapy for r/r CD7+ Acute Leukemia

Who this might be right for
T Lymphoblastic Leukemia/LymphomaMixed Phenotype Acute LeukemiaAcute Myeloid Leukemia
The First Affiliated Hospital of Soochow University 20
Very early researchNot Yet RecruitingNCT06849401
What this trial is testing

The Safety and Efficacy of VGO-Cs01p in Patients With CD7-positive Relapsed/Refractory Acute T-lymphoblastic Leukemia

Who this might be right for
T-ALL
Shanghai Jiao Tong University School of Medicine 9
Early research (Phase 1)Enrolling By InvitationNCT07784309
What this trial is testing

A Clinical Study of HY035 Cell Injection in the Treatment of CD7-positive Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Acute T Cell Lymphoblastic LeukemiaLymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) RefractoryAcute Myeloid Leukemia (AML)+1 more
Institute of Hematology & Blood Diseases Hospital, China 13
Testing effectiveness (Phase 2)UnknownNCT02742727
What this trial is testing

CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma

Who this might be right for
Acute Myeloid LeukemiaPrecursor T-Cell Lymphoblastic Leukemia-LymphomaT-cell Prolymphocytic Leukemia+6 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10